Navigation Links
New Combo Therapy May Prevent TB, Save Lives in People With HIV
Date:7/6/2011

WEDNESDAY, July 6 (HealthDay News) -- Simpler and shorter treatment with antibiotic drugs could help prevent full-blown tuberculosis in millions of people worldwide infected with the bacterium that causes TB, especially those also infected with HIV, researchers report.

TB, or tuberculosis, is the leading cause of death among people co-infected with HIV, the virus that causes AIDS. About half a million people with both infections die worldwide every year.

The new study by an international team of scientists included 1,148 South African men and women infected with the TB bacterium and HIV, who were followed for up to six years to see whose TB infections stayed dormant.

It found that the most streamlined combination treatment -- a high dose of 900 milligrams each of the newer antibiotic rifapentine (Priftin) and the traditional anti-TB antibiotic isoniazid once weekly for three months -- worked as well or better than the current gold standard of care of 300 mg of isoniazid taken daily for six months or longer.

Of the study volunteers, about 3.1 percent on the shorter drug regimen developed active TB or died each year, compared to 3.6 among those on the standard daily regimen. Without treatment, researchers estimated that the mortality rate would have doubled.

Compliance with the drug regimen was also 95 percent for the shorter regimen, compared to 60 percent that other studies showed for the standard regimen.

The study appears online July 7 in the New England Journal of Medicine.

"This new, simpler treatment regimen with rifapentine and isoniazid is highly effective and could transform therapy for latent tuberculosis in both those co-infected with HIV and those not," senior author Dr. Richard Chaisson, a professor of infectious diseases at the Johns Hopkins University School of Medicine and founding director of its Center for Tuberculosis Research, said in a Hopkins news release.

"New treatment options are urgently needed to help control TB globally, and simpler regimens will substantially increase the number of people receiving therapy," Chaisson added.

He noted that fewer than 1 percent of those infected and most likely to develop full-blown TB receive drug treatment because of factors such as inconvenience, drug side effects and difficulty finding nearby health clinics.

More information

The U.S. National Institute of Allergy and Infectious has more about TB.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, July 7, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vitamin D, Calcium Combo May Halve Melanoma Risk in Some Women
2. Energy Drink-Vodka Combo Nearly Kills Teen
3. Daily Four-Drug Combo Pill Halves Heart Disease Risk: Study
4. Combo of Paxil, Pravachol May Raise Blood Sugar
5. Chemo Combo May Help Stave Off Pancreatic Cancer Death
6. Alcohol-Energy Drink Combo Riskier Than Booze Alone, Study Says
7. Low-Intensity Exercise, Drug Combo Can Help Parkinsons Patients, Studies Show
8. Diet-Exercise Combo Seems to Work Best for Obese Seniors
9. Risks May Outweigh Benefits for Blood Pressure Drug Combo
10. In Women, Diabetes Plus Depression a Deadly Combo
11. New combo lung cancer therapy improves survival over single-line treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Combo Therapy May Prevent TB, Save Lives in People With HIV
(Date:2/28/2017)... ... February 28, 2017 , ... ... a healthcare automation intelligence company based in New York. , “Ensuring an intuitive, ... provider’s workflow remains unaltered. Those two fundamental reasons are the reasons this acquisition ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... 7, 2017, from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE ... financial compliance, performance analytics, and engagement strategies. , The discussion will include best ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... alternative health care industry, announces Chris Brandl as its New Guest Director. ... and purpose to corporations throughout his career. He began his professional career at ...
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Orange County ... a chronic inflammatory gum condition that occurs when the bacteria in plaque infect the ... referred to as a scaling and root planing or SRP, and can include surgical ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... ... and Markets has announced the addition of the "Rheumatoid Arthritis Drugs ... The latest research Rheumatoid Arthritis Drugs Price Analysis and Strategies ... Arthritis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Rheumatoid ...
(Date:2/28/2017)... SAN FRANCISCO , February 27, 2017 ... D BioMedical assets for ...   LOI contemplates capital infusion into Amarantus ... value   Amarantus names four new appointees to its Board ... SeD Biomedical Inc. (SeD Biomedical) , ...
(Date:2/28/2017)... , Feb. 27, 2017  Market Research presents an all-encompassing ... fiber optics market titled ,Medical Fiber Optics Market: Global Industry ... and trends globally across the five key regions of ... , Europe , APAC and MEA which ... medical fiber optics market over the forecast period. In this ...
Breaking Medicine Technology: